Dr. James Luyendyk, an accomplished researcher and the Albert and Lois Dehn Endowed Professor of Pathobiology and Diagnostic Investigation at Michigan State University, has been named the College of Veterinary Medicine’s Associate Dean for Research and Graduate Studies, effective May 1, 2025.

In this role, Luyendyk will lead the College’s research initiatives, support faculty in securing funding, and strengthen partnerships with funding agencies and collaborators. He brings extensive experience in research leadership, with a focus on hepatotoxicity, liver repair, and the role of the hemostatic system in liver disease.

“Dr. Luyendyk’s boundless enthusiasm for scientific discovery, coupled with his established dedication to supporting students and researchers, will make him an inspiring leader of the College’s research enterprise,” says Kim Dodd, Dean, College of Veterinary Medicine. “His dynamic approach to fostering interdisciplinary collaboration will strengthen CVM’s role in advancing veterinary and comparative medicine research and maximize our collective impact.”

Since joining the College in 2012, Luyendyk has published more than 135 peer-reviewed papers and earned recognition from leading scientific organizations. He currently serves as Vice President-elect of the Society of Toxicology, Co-chair of the International Society on Thrombosis and HISTH SSC Subcommittee on Hemostatic Management of Patients with Liver Disease, and Councillor for the International Fibrinogen Research Society. His contributions to the field have been recognized with numerous awards, including the Society of Toxicology Achievement Award and election as a Fellow of the Academy of Toxicological Sciences.

Luyendyk earned his PhD in Pharmacology and Toxicology at MSU and pursued postdoctoral training in Immunology and Hemostasis at the Scripps Research Institute. His passion for research and mentorship will play a key role in driving innovation at the College.

“I’m excited to take on this role and support the College’s researchers in advancing scientific discovery,” says Luyendyk. “We need to maximize the impact of our research in veterinary and human health by encouraging durable collaboration, and by providing our scientists and clinicians with the technical and intellectual resources required to pursue their best ideas.”

Luyendyk’s leadership will be instrumental in shaping the College’s research strategy and furthering its mission to drive discovery in animal and human health.

He succeeds Dr. Colleen Hegg, who led the unit as Interim Associate Dean for Research and Graduate Studies since August 2024. She will continue to serve as Director of the CVM Comparative Medicine and Integrative Biology Program.